New blood pressure drug enters Mid-Stage testing
NCT ID NCT07297797
Summary
This study is testing a new drug called HRS-9563 to see if it can safely lower blood pressure in adults with mild to moderate hypertension. About 234 participants will receive either the drug or a placebo for up to 9 months while researchers monitor their blood pressure. The goal is to find the right dose and see how well it works compared to no treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MILD TO MODERATE HYPERTENSION are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital, Capital Medical University
RECRUITINGBeijing, Beijing Municipality, 100029, China
Contact
Conditions
Explore the condition pages connected to this study.